Faramarz Edalat MD, Presenter: Nothing to Disclose

Nima Kokabi MD, Abstract Co-Author: Nothing to Disclose

Juan Camilo Camacho, Abstract Co-Author: Nothing to Disclose

Courtney Ann Coursey Moreno MD, Abstract Co-Author: Nothing to Disclose

Pardeep Kumar Mittal MD, Abstract Co-Author: Nothing to Disclose

The purpose of this exhibit is to: • Explain the role of MRI as an invaluable tool in diagnosing rare liver tumors and its mimics due to its excellent soft tissue contrast • Review MR imaging characteristics of rare liver tumors • Understand the pathological correlation of rare liver tumors with their MR imaging findings • Discuss the role of MR imaging in supporting effective treatment decision making 

• Basic approaches to rare liver tumors • MRI protocol for evaluation of rare liver tumors • MR imaging features and pathological correlation of rare liver tumors including epitheloid hemangioendothelioma, hepatic angiosarcoma, biliary cystadenoma and cystadenocarcinoma, primary hepatic lymphoma and neuroendocrine tumors, and angiomyolipoma • Treatment approaches based on MRI findings • Conclusion

http://abstract.rsna.org/uploads/2014/14009743/14009743_xrk8.pdf

Edalat, F, Kokabi, N, Camacho, J, Coursey Moreno, C, Mittal, P, Rare Primary Liver Tumors: Magnetic Resonance Imaging and Pathological Correlation.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14009743.html